Effects of (-)-epicatechin on molecular modulators of skeletal muscle growth and differentiation

Journal of Nutritional Biochemistry

Volumn 25, Issue 1, 2014, Pages 91-94

  Gutierrez Salmean, Gabriela ^a   Ciaraldi, Theodore P ^b,c   Nogueira, Leonardo ^a   Barboza, Jonathan ^b   Taub, Pam R ^b   Hogan, Michael C ^b   Henry, Robert R ^b,c   Meaney, Eduardo ^a   Villarreal, Francisco ^b   Ceballos, Guillermo ^a   Ramirez Sanchez, Israel ^a,b  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Epicatechin; Flavonoids; Sarcopenia

Indexed keywords

BETA GALACTOSIDASE; EPICATECHIN; FOLLISTATIN; MYOD PROTEIN; MYOGENIC FACTOR 5; MYOGENIN; MYOSTATIN;

ADULT; AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GRIP STRENGTH; GROWTH REGULATION; HAND GRIP; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; MOUSE; MUSCLE DEVELOPMENT; MUSCLE GROWTH; MUSCLE STRENGTH; NONHUMAN; NORMAL HUMAN; PROTEIN BLOOD LEVEL; QUADRICEPS FEMORIS MUSCLE; SARCOPENIA; SENESCENCE; SKELETAL MUSCLE; TREATMENT DURATION;

EPICATECHIN; FLAVONOIDS; SARCOPENIA;

ADULT; AGING; ANIMALS; BETA-GALACTOSIDASE; CACAO; CATECHIN; CELL DIFFERENTIATION; FOLLISTATIN; HAND STRENGTH; HUMANS; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; MUSCLE, SKELETAL; MYOD PROTEIN; MYOGENIC REGULATORY FACTOR 5; MYOGENIN; MYOSTATIN; PILOT PROJECTS; SARCOPENIA; YOUNG ADULT;

EID: 84889570866     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2013.09.007     Document Type: Article

References (18)

1. Marzetti E., Leeuwenburgh C. Skeletal muscle apoptosis, sarcopenia and frailty at old age. Exp Gerontol 2006, 41:1234-1238.
2. Eldadah B.A. Fatigue and fatigability in older adults. PM R. 2010, 2:406-413.
3. Ruiz J.R., Sui X., Lobelo F., Morrow J.R., et al. Association between muscular strength and mortality in men: Prospective cohort study. BMJ 2008, 337:a439.
4. Buitrago-Lopez A., Sanderson J., Johnson L., et al. Chocolate consumption and cardiometabolic disorders: Systematic review and meta-analysis. BMJ 2011, 343:d4488.
5. Taub P., Ramirez-Sanchez I., Ciaraldi T., et al. Alterations in skeletal muscle indicators of mitochondrial structure and biogenesis in patients with type 2 diabetes and heart failure: Effects of epicatechin rich cocoa. Clin Trans Sci. 2012, 5:43-47.
6. Nogueira L., Ramirez-Sanchez I., Perkins G., et al. (-)-Epicatechin enhances fatigue resistance and oxidative capacity in mouse muscle. J Physiol 2011, 589:4615-4631.
7. Ramirez-Sanchez I., Nogueira L., Moreno A., et al. Stimulatory effects of the flavanol (-)-epicatechin on cardiac angiogenesis: Additive effects with exercise. J Cardiovasc Pharmacol 2012, 60:429-438.
8. Basaria S., Bhasin S. Targeting the skeletal muscle-metabolism axis in prostate-cancer therapy. N Engl J Med 2012, 367:965-967.
9. Sikora E., Arendt T., Bennett M., Narita M. Impact of cellular senescence signature on ageing research. Ageing Res Rev 2011, 10:146-152.
10. Mok G.F., Sweetman D. Many routes for the same destination: Lessons from skeletal muscle development. Reproduction 2010, 141:301-312.
11. Dalbo V.J., Roberts M.D., Sunderland K.L., et al. Acute loading and aging effects on myostatin pathway biomarkers in human skeletal muscle after three secuential bouts of resistance exercise. J Gerontol A Biol Sci Med Sci 2011, 66:855-865.
12. Hansen J., Brandt C., Nielsen A.R., et al. Exercise induces a marked increase in plasmafollistatin: Evidence that follistatin is a contraction-induced hepatokine. Endocrinology 2011, 152:164-171.
13. Burton L.A., Sumukadas D. Optimal management of sarcopenia. Clin Interv Aging 2010, 5:217-228.
14. Ayasolla K.R., Singh A.K., Singh I. 5-Aminoimidazole-4-carboxamide-1-beta-4- ribofuranoside (aicar) attenuates the expression of lps- and abeta peptide-induced inflammatory mediators in astroglia. J Neuroinflammation 2005, 2:21.
15. Corti R., Flammer A.J., Hollenberg N.K., Luscher T.F. Cocoa and cardiovascular health. Circulation 2009, 119:1433-1441.
16. Schroeter H., Heiss C., Balzer J., et al. (-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Natl Acad Sci U S A 2006, 103:1024-1029.
17. Matsumoto N., Yamakawa M., Suoma K., Hara Y. Repeated dose toxicity study of green tea extract in rat. Jpn Pharm Ther 1999, 27:1701-1707.
18. Huttemann M., Lee I., Malek M.H. (-)-Epicatechin maintains endurance training adaptation in mice after 14 days of detraining. FASEB J 2011, 26:1413-1422.